{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:20:46Z","timestamp":1781191246019,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>To investigate the complete clinical spectrum of individuals with paediatric tuberous sclerosis complex in southern Sweden and explore changes over time.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective observational study, 52 individuals aged up to 18 years at the study start were followed-up at regional hospitals and centres for habilitation from 2000 to 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Cardiac rhabdomyoma was detected prenatally\/neonatally in 69.2% of the subjects born during the latest ten years of the study period. Epilepsy was diagnosed in 82.7% of subjects, and 10 (19%) were treated with everolimus, mainly (80%) for a neurological indication. Renal cysts were detected in 53%, angiomyolipomas in 47%, astrocytic hamartomas in 28% of the individuals. There was a paucity of standardized follow-up of cardiac, renal, and ophthalmological manifestations and no structured transition to adult care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our in-depth analysis shows a clear shift towards an earlier diagnosis of tuberous sclerosis complex in the latter part of the study period, where more than 60% of cases showed evidence of this condition already <jats:italic>in utero<\/jats:italic> due to the presence of a cardiac rhabdomyoma. This allows for preventive treatment of epilepsy with vigabatrin and early intervention with everolimus for potential mitigation of other symptoms of tuberous sclerosis complex.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-023-04137-4","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:02:09Z","timestamp":1688032929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Childhood tuberous sclerosis complex in southern Sweden: a paradigm shift in diagnosis and treatment"],"prefix":"10.1186","volume":"23","author":[{"given":"Kevin","family":"Pearsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josefin","family":"Bj\u00f6rk Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Gr\u00e4nse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"K\u00e4ll\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivile","family":"Bekassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"key":"4137_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","volume":"123","author":"H Northrup","year":"2021","unstructured":"Northrup H, Aronow ME, Bebin EM, Bissler J, Darling TN, de Vries PJ, Frost MD, Fuchs Z, Gosnell ES, Gupta N, et al. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations. Pediatr Neurol. 2021;123:50\u201366.","journal-title":"Pediatr Neurol"},{"key":"4137_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.seizure.2017.10.005","volume":"53","author":"KO Welin","year":"2017","unstructured":"Welin KO, Carlqvist P, Svensson A, Althin R, Eklund E, Rask O. Epilepsy in tuberous sclerosis patients in Sweden - Healthcare utilization, treatment, morbidity, and mortality using national register data. Seizure. 2017;53:4\u20139.","journal-title":"Seizure"},{"key":"4137_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","volume":"20","author":"CL Salussolia","year":"2019","unstructured":"Salussolia CL, Klonowska K, Kwiatkowski DJ, Sahin M. Genetic etiologies, diagnosis, and treatment of Tuberous Sclerosis Complex. Annu Rev Genomics Hum Genet. 2019;20:217\u201340.","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"4137_CR4","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","volume":"2","author":"EP Henske","year":"2016","unstructured":"Henske EP, Jozwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;2:16035.","journal-title":"Nat Rev Dis Primers"},{"key":"4137_CR5","unstructured":"Krueger DA, Northrup H, International Tuberous Sclerosis Complex Consensus G. : Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013, 49(4):255\u2013265."},{"issue":"3","key":"4137_CR6","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1159\/000510222","volume":"237","author":"CC Wei","year":"2021","unstructured":"Wei CC, Hsiao YP, Gau SY, Wu YT, Wu CT, Wu MH, Tsai JD. The efficacy of Everolimus for Facial Angiofibromas in Tuberous Sclerosis Complex Patients treated for renal Angiomyolipoma\/Subependymal giant cell astrocytoma. Dermatology. 2021;237(3):444\u20139.","journal-title":"Dermatology"},{"issue":"10056","key":"4137_CR7","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French JA, Lawson JA, Yapici Z, Ikeda H, Polster T, Nabbout R, Curatolo P, de Vries PJ, Dlugos DJ, Berkowitz N, et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet. 2016;388(10056):2153\u201363.","journal-title":"Lancet"},{"issue":"6","key":"4137_CR8","doi-asserted-by":"publisher","first-page":"e0158476","DOI":"10.1371\/journal.pone.0158476","volume":"11","author":"DN Franz","year":"2016","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost MD, Kuperman R, Witt O, Kohrman MH, Flamini JR, Wu JY, et al. Long-term use of Everolimus in patients with tuberous sclerosis complex: final results from the EXIST-1 study. PLoS ONE. 2016;11(6):e0158476.","journal-title":"PLoS ONE"},{"issue":"11","key":"4137_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","volume":"14","author":"HC Lam","year":"2018","unstructured":"Lam HC, Siroky BJ, Henske EP. Renal disease in tuberous sclerosis complex: pathogenesis and therapy. Nat Rev Nephrol. 2018;14(11):704\u201316.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"4137_CR10","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.1528-1167.2009.02474.x","volume":"51","author":"CJ Chu-Shore","year":"2010","unstructured":"Chu-Shore CJ, Major P, Camposano S, Muzykewicz D, Thiele EA. The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010;51(7):1236\u201341.","journal-title":"Epilepsia"},{"issue":"2","key":"4137_CR11","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.25956","volume":"89","author":"K Kotulska","year":"2021","unstructured":"Kotulska K, Kwiatkowski DJ, Curatolo P, Weschke B, Riney K, Jansen F, Feucht M, Krsek P, Nabbout R, Jansen AC, et al. Prevention of Epilepsy in Infants with Tuberous Sclerosis Complex in the EPISTOP Trial. Ann Neurol. 2021;89(2):304\u201314.","journal-title":"Ann Neurol"},{"issue":"6","key":"4137_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.pediatrneurol.2013.08.017","volume":"49","author":"J Roth","year":"2013","unstructured":"Roth J, Roach ES, Bartels U, Jozwiak S, Koenig MK, Weiner HL, Franz DN, Wang HZ. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol. 2013;49(6):439\u201344.","journal-title":"Pediatr Neurol"},{"issue":"6","key":"4137_CR13","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on therapeutic strategies. Epilepsia. 2010;51(6):1069\u201377.","journal-title":"Epilepsia"},{"issue":"2","key":"4137_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3109\/08880018.2012.734896","volume":"30","author":"A Kocabas","year":"2013","unstructured":"Kocabas A, Ekici F, Cetin II, Emir S, Demir HA, Ari ME, Degerliyurt A, Guven A. Cardiac rhabdomyomas associated with tuberous sclerosis complex in 11 children: presentation to outcome. Pediatr Hematol Oncol. 2013;30(2):71\u20139.","journal-title":"Pediatr Hematol Oncol"},{"issue":"1","key":"4137_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13023-018-0764-z","volume":"13","author":"M Slowinska","year":"2018","unstructured":"Slowinska M, Jozwiak S, Peron A, Borkowska J, Chmielewski D, Sadowski K, Jurkiewicz E, Vignoli A, La Briola F, Canevini MP, et al. Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures? Orphanet J Rare Dis. 2018;13(1):25.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"4137_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/0002-9378(82)90484-7","volume":"143","author":"GR DeVore","year":"1982","unstructured":"DeVore GR, Hakim S, Kleinman CS, Hobbins JC. The in utero diagnosis of an interventricular septal cardiac rhabdomyoma by means of real-time-directed, M-mode echocardiography. Am J Obstet Gynecol. 1982;143(8):967\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"4137_CR17","doi-asserted-by":"publisher","first-page":"e001493","DOI":"10.1161\/JAHA.114.001493","volume":"3","author":"RB Hinton","year":"2014","unstructured":"Hinton RB, Prakash A, Romp RL, Krueger DA, Knilans TK, International Tuberous Sclerosis, Consensus G. Cardiovascular manifestations of tuberous sclerosis complex and summary of the revised diagnostic criteria and surveillance and management recommendations from the International Tuberous Sclerosis Consensus Group. J Am Heart Assoc. 2014;3(6):e001493.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"4137_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/heart.90.1.43","volume":"90","author":"M Emmel","year":"2004","unstructured":"Emmel M, Brockmeier K, Sreeram N. Rhabdomyoma as accessory pathway: electrophysiologic and morphologic confirmation. Heart. 2004;90(1):43.","journal-title":"Heart"},{"issue":"2","key":"4137_CR19","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1017\/S1047951120003819","volume":"31","author":"Y Nir-David","year":"2021","unstructured":"Nir-David Y, Brosilow S, Khoury A. Rapid response of a cardiac rhabdomyoma causing severe right ventricular outflow obstruction to Sirolimus in an infant with negative genetics for tuberous sclerosis. Cardiol Young. 2021;31(2):312\u20134.","journal-title":"Cardiol Young"},{"issue":"12","key":"4137_CR20","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1111\/echo.13015","volume":"32","author":"R Wagner","year":"2015","unstructured":"Wagner R, Riede FT, Seki H, Hornemann F, Syrbe S, Daehnert I, Weidenbach M. Oral Everolimus for treatment of a Giant Left Ventricular Rhabdomyoma in a Neonate-Rapid Tumor Regression documented by real time 3D Echocardiography. Echocardiography. 2015;32(12):1876\u20139.","journal-title":"Echocardiography"},{"issue":"1","key":"4137_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/epi4.12286","volume":"4","author":"R Nabbout","year":"2019","unstructured":"Nabbout R, Belousova E, Benedik MP, Carter T, Cottin V, Curatolo P, Dahlin M, d\u2019Augeres LDA, de Vries GB. Epilepsy in tuberous sclerosis complex: findings from the TOSCA Study. Epilepsia Open. 2019;4(1):73\u201384.","journal-title":"Epilepsia Open"},{"issue":"3","key":"4137_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1111\/dmcn.14356","volume":"62","author":"C Tye","year":"2020","unstructured":"Tye C, McEwen FS, Liang H, Underwood L, Woodhouse E, Barker ED, Sheerin F, Yates JRW, Bolton PF. Tuberous sclerosis study G: long-term cognitive outcomes in tuberous sclerosis complex. Dev Med Child Neurol. 2020;62(3):322\u20139.","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"4137_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11689-022-09423-3","volume":"14","author":"S Vanclooster","year":"2022","unstructured":"Vanclooster S, Bissell S, van Eeghen AM, Chambers N, De Waele L, Byars AW, Capal JK, Cukier S, Davis P, Flinn J, et al. The research landscape of tuberous sclerosis complex-associated neuropsychiatric disorders (TAND)-a comprehensive scoping review. J Neurodev Disord. 2022;14(1):13.","journal-title":"J Neurodev Disord"},{"issue":"10","key":"4137_CR24","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/sj.ki.5001853","volume":"70","author":"SK Rakowski","year":"2006","unstructured":"Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int. 2006;70(10):1777\u201382.","journal-title":"Kidney Int"},{"issue":"6","key":"4137_CR25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/ckj\/sfx094","volume":"10","author":"MJ Buj Pradilla","year":"2017","unstructured":"Buj Pradilla MJ, Marti Balleste T, Torra R, Villacampa Auba F. Recommendations for imaging-based diagnosis and management of renal angiomyolipoma associated with tuberous sclerosis complex. Clin Kidney J. 2017;10(6):728\u201337.","journal-title":"Clin Kidney J"},{"key":"4137_CR26","unstructured":"Northrup H, Krueger DA, International Tuberous Sclerosis Complex Consensus G. : Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013, 49(4):243\u2013254."},{"issue":"2","key":"4137_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.trre.2007.12.001","volume":"22","author":"E Letavernier","year":"2008","unstructured":"Letavernier E, Legendre C. mToR inhibitors-induced proteinuria: mechanisms, significance, and management. Transpl Rev (Orlando). 2008;22(2):125\u201330.","journal-title":"Transpl Rev (Orlando)"},{"issue":"2","key":"4137_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000448293","volume":"134","author":"JC Kingswood","year":"2016","unstructured":"Kingswood JC, Bissler JJ, Budde K, Hulbert J, Guay-Woodford L, Sampson JR, Sauter M, Cox J, Patel U, Elmslie F, et al. Review of the tuberous sclerosis renal guidelines from the 2012 Consensus Conference: Current Data and Future Study. Nephron. 2016;134(2):51\u20138.","journal-title":"Nephron"},{"key":"4137_CR29","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jpeds.2017.05.015","volume":"187","author":"BJ Siroky","year":"2017","unstructured":"Siroky BJ, Towbin AJ, Trout AT, Schafer H, Thamann AR, Agricola KD, Tudor C, Capal J, Dixon BP, Krueger DA, et al. Improvement in renal cystic disease of Tuberous Sclerosis Complex after treatment with mammalian target of rapamycin inhibitor. J Pediatr. 2017;187:318\u2013322e312.","journal-title":"J Pediatr"},{"key":"4137_CR30","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2147\/EB.S186306","volume":"11","author":"MJ Wan","year":"2019","unstructured":"Wan MJ, Chan KL, Jastrzembski BG, Ali A. Neuro-ophthalmological manifestations of tuberous sclerosis: current perspectives. Eye Brain. 2019;11:13\u201323.","journal-title":"Eye Brain"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-023-04137-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-023-04137-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T10:05:25Z","timestamp":1688033125000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-023-04137-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4137"],"URL":"https:\/\/doi.org\/10.1186\/s12887-023-04137-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"8 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (reference no. 2020\u201305201). Data disclosure was approved by the consultation group for quality registries, care databases, and preparation in Region Sk\u00e5ne (reference no. 214\u2009\u2212\u200919). As the nature of the study was retrospective, the Swedish Ethical Review Authority waived Informed consent for this study.The study was performed in accordance with the declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"329"}}